Browsing by Author JMI Labs Inc

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 12 of 12
Issue DateTitleAuthor(s)
1-Mar-2006Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agentsSader, Helio S. [UNIFESP]; Fritsche, Thomas R.; Jones, Ronald N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ
1-Aug-2005Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strainsSader, Helio S. [UNIFESP]; Fritsche, Thomas R.; Kaniga, Kone; Ge, Yi Gong; Jones, Ronald N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Peninsula Pharmaceut; Tufts Univ
1-Jun-2012Antimicrobial activity of daptomycin in comparison to glycopeptides and other antimicrobials when tested against numerous species of coagulase-negative StaphylococcusSader, Hello S. [UNIFESP]; Jones, Ronald N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ
1-Aug-2011Antimicrobial Activity of Daptomycin Tested Against Gram-Positive Strains Collected in European Hospitals: Results from 7 Years of Resistance Surveillance (2003-2009)Sader, Helio Silva [UNIFESP]; Farrell, D. J.; Jones, R. N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ
1-Jul-2011Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010)Sader, Helio S. [UNIFESP]; Moet, Gary J.; Farrell, David J.; Jones, Ronald N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ
1-Sep-2006Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)Sader, Helio Silva [UNIFESP]; Streit, J. M.; Fritsche, T. R.; Jones, R. N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ
1-Feb-2005Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilliSader, H. S.; Jones, R. N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ
1-Feb-2004Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001)Mutnick, A. H.; Rhomberg, P. R.; Sader, Helio S. [UNIFESP]; Jones, R. N.; JMI Labs Inc; Univ Iowa; Tufts Univ; Universidade Federal de São Paulo (UNIFESP)
1-Jun-2006Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY antimicrobial surveillance program (1998-2004)Castanheira, Mariana; Gales, Ana C.; Pignatari, Antonio C. C.; Jones, Ronald N.; Sader, Helio S.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP)
1-Dec-2005Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion testsJones, R. N.; Fritsche, T. R.; Ge, Y. G.; Kaniga, K.; Sader, Helio S. [UNIFESP]; JMI Labs Inc; Tufts Univ; Peninsula Pharmaceut; Universidade Federal de São Paulo (UNIFESP)
1-May-2007In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004)Sader, Helio S.; Fritsche, Thomas R.; Jones, Ronald N.; JMI Labs Inc; Tufts Univ; Universidade Federal de São Paulo (UNIFESP)
1-Jul-2005Potency and spectrum trends for cefepime tested against 65,746 clinical bacterial isolates collected in North American medical centers: Results from the SENTRY Antimicrobial Surveillance Program (1998-2003)Sader, H. S.; Fritsche, T. R.; Jones, R. N.; JMI Labs Inc; Universidade Federal de São Paulo (UNIFESP); Tufts Univ